公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2017 | Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients | Gligorov J.; Ataseven B.; Verrill M.; de Laurentiis M.; Jung K.H.; Azim H.A.; Al-Sakaff N.; Lauer S.; Shing M.; Pivot X.; Koroveshi D.; Bouzid K.; Casalnuovo M.; Cascallar D.; Korbenfeld E.P.; Bastick P.; Beith J.; Colosimo M.; Friedlander M.; Ganju V.; Green M.; Patterson K.; Redfern A.; Richardson G.; Ceric T.; Gordana K.; Beato C.A.; Ferrari M.; Hegg R.; Helena V.; Ismael G.F.; Lessa A.E.; Mano M.; Morelle A.; Nogueira J.A.; Timcheva K.; Tomova A.; Tsakova M.; Zlatareva-Petrova A.; Asselah J.; Assi H.; Brezden-Masley C.; Chia S.; Freedman O.; Harb M.; Joy A.A.; Kulkarni S.; Prady C.; Gaete A.A.A.; Matamala L.; Torres R.; Yanez E.; Franco S.; Urrego M.; Gugi? D.; Vrbanec D.; Melichar B.; Prausov? J.; Vyzula R.; Pilarte R.G.; Le?n M.I.; Mu?oz R.; Ramos G.; Azeem H.A.; Aziz A.A.; El Zawahry H.; Osegueda F.R.; Alexandre J.; Artignan X.; Barletta H.; Beguier E.; Berdah J.-F.; Marty C.B.; Bollet M.; Bourgeois H.; Bressac C.; Burki F.; Campone M.; Coeffic D.; Cojocarasu O.Z.; Dagada C.; Dalenc F.; Del Piano F.; Desauw C.; Desmoulins I.; Dohollou N.; Egreteau J.; Ferrero J.-M.; Foa C.; Garidi R.; Gasnault L.; Guardiola E.; Hamizi S.; Jarcau R.; Jacquin J.-P.; Jaubert D.; Jolimoy G.; Mineur H.L.; Largillier R.; Leduc B.; Martin P.; Melis A.; Monge J.; Moullet I.; Mousseau M.; Nguyen S.; Orfeuvre H.; Petit T.; Priou F.; Bach I.S.; Simon H.; Stefani L.; Uwer L.; Youssef A.; Aktas B.; von der Assen A.; Augustin D.; Balser C.; Bauer L.-E.; Bechtner C.; Beyer G.; Brucker C.; B?ckner U.; Busch S.; Christensen B.; Deryal M.; Farrokh A.; Faust E.; Friedrichs K.; Graf H.; Griesshammer M.; Grischke E.-M.; H?nle C.; Heider A.; Henschen S.; Hesse T.; Jackisch C.; Kisro J.; K?hler A.; Kuemmel S.; Lampe D.; Lantzsch T.; Latos K.; Lex B.; Liedtke C.; Luedders D.; Maintz C.; M?ller V.; Overkamp F.; Park-Simon T.-W.; Paul M.; Prechtl A.; Ringsdorf U.; Runnebaum I.; Ruth S.; Salat C.; Scheffen I.; Schilling J.; Schmatloch S.; Schmidt M.; Schneeweiss A.; Schrader I.; Seipelt G.; Simon E.; Stefek A.; Stickeler E.; Thill M.; Tio J.; Tuczek A.; Warm M.; Weigel M.; Wischnik A.; Wojcinski S.; Ziegler-L?hr K.; Aravantinos G.; Ardavanis A.; Fountzilas G.; Gogas H.; Kakolyris S.; Mavroudis D.; Papadimitriou C.; Papandreou C.; Papazisis K.; Castro H.; Hernandez-Monroy C.E.; Ngan R.; Yeo W.; Bittner N.; Boer K.; Csejtei A.; Horvath Z.; Kocsis J.; Mangel L.C.; Mezei K.; Nagy Z.; Szanto J.; Atmakusuma D.; Fadjari H.; Kurnianda D.; Prayogo N.; Tanggo E.H.; Coate L.; Hennessy B.; Kelly C.; Martin M.; Nasim S.; O'Connor M.; Aieta M.; Allegrini G.; Amadori D.; Bidoli P.; Biti G.; Bordonaro R.; Bottini A.; Carterni G.; Cavanna L.; Cazzaniga M.; Cognetti F.; Contu A.; Cruciani G.; Donadio M.; Falcone A.; Farci D.; Forcignan? R.C.; Frassoldati A.; Gaion F.; Gamucci T.; Giotta F.; Livi L.; Lorusso V.; Maiello E.; Marchetti P.; Mariani G.; Mion M.; Moscetti L.; Musolino A.; Pazzola A.; Pedrazzoli P.; Pigi A.; de Placido S.; Caremoli E.R.; Santoro A.; Tienghi A.; Ahn J.-S.; Lee K.S.; Lee S.H.; Seo J.H.; Sohn J.-H.; Cesas A.; Juozaityte E.; Cheah N.L.C.; Chong F.L.T.; Devi B.C.R.; Phua V.; Teoh D.; Ching L.W.; Yusof M.; Corona J.; Dominguez A.; Mendoza R.L.G.; Hernandez C.A.; Ramiro A.J.; Santos J.M.; Espinosa P.M.; Villarreal Garza C.M.; Errihani H.; Bakker S.; van den Berkmortel F.; Blaisse R.J.B.; Huinink D.T.B.; van den Bosch J.; Braun J.J.; Dercksen M.W.; Droogendijk H.; Erdkamp F.; Haringhuizen A.; de Jongh F.E.; Kok T.C.; Los M.; Madretsma S.; Terwogt J.M.M.; van der Padt A.; van Rossum-Schornagel Q.C.; Smilde T.J.; de Valk B.; van der Velden A.; van Warmerdam L.; van de Wouw A.J.; North R.; Kersten C.; Mjaaland I.; Wist E.; Aziz Z.; Masood N.; Rashid K.; Shah M.; Alcedo J.C.; Aleman D.; Neciosup S.; Reategui R.; Valdiviezo N.; Vera L.; Fernando G.; Roque F.; Strebel H.M.; Krzemieniecki K.; Litwiniuk M.; Mruk A.; Pienkowski T.; Sawrycki P.; Slomian G.; Tomczak P.; Afonso N.; Cardoso F.; Damasceno M.; Nave M.; Badulescu F.; Ciule L.; Curescu S.; Eniu A.; Filip D.; Grecea D.; Jinga D.-C.; Lungulescu D.; Oprean C.M.; Stanculeanu D.L.; Turdean M.; Dvornichenko V.; Emelyanov S.; Lichinitser M.; Manikhas A.; Sakaeva D.; Shirinkin V.; Stroyakovskiy D.; Abulkhair O.; Zekri J.; Filipovic S.; Kovcin V.; Nedovic J.; Pesic J.; Vasovic S.; Ng R.; Bystricky B.; Leskova J.; Mardiak J.; Mi?urov? E.; Wagnerova M.; Taka? I.; Demetriou G.S.; Dreosti L.; Govender P.; Jordaan J.P.; Veersamy P.; Romero J.L.A.; Lopez N.B.; Arias C.C.; Chacon J.; Aramburo A.F.; Morales L.A.F.; Garcia M.; Estevez L.G.; Garcia-Palomo Perez A.; Garcia Saenz J.A.; Garcia Sanchis L.; Cubells L.G.; Cortijo L.G.; Santiago S.G.; De Aranguiz B.H.F.; Ma?as J.J.I.; Gallego P.J.; Cussac A.L.; Ferrandiz C.L.; Garrido M.L.; Alvarez P.L.; Vega J.M.L.; Del Prado P.M.; Ja?ez N.M.; Murillo S.M.; Rosales A.M.; Jaso L.M.; Fernandez I.P.; Martorell A.P.; Carrion R.P.; Simon S.P.; Alcibar A.P.; Lorenzo J.P.; Garcia V.Q.; Asensio T.R.Y.C.; Maicas M.D.T.; Villanueva Silva M.J.; Killander F.; Svensson J.H.; Fehr M.; Hauser N.; M?ller A.; Pagani O.; Passmann-Kegel H.; Popescu R.; Rabaglio M.; Rauch D.; Schlatter C.; Zaman K.; Chang T.-W.; CHIUN-SHENG HUANG ; Wang H.-C.; Yu J.-C.; Bandidwattanawong C.; Maneechavakajorn J.; Seetalarom K.; Dejthevaporn T.S.; Somwangprasert A.; Vongsaisuwon M.; Akbulut H.; Altundag K.; Arican A.; Bozcuk H.; Eralp Y.; Idris M.; Isikdogan A.; Senol C.H.; Sevinc A.; Uygun K.; Yucel E.; Yucel I.; Yumuk F.; Shparyk Y.; Voitko N.; Jaloudi M.; Adams J.; Agrawal R.; Ahmed S.; Alhasso A.; Allerton R.; Anwar S.; Archer C.; Ashford R.; Barraclough L.; Bertelli G.; Bishop J.; Branson T.; Butt M.; Chakrabarti A.; Chakraborti P.; Churn M.; Crowley C.; Davis R.; Dhadda A.; Eldeeb H.; Fraser J.; Hall J.; Hickish T.; Hogg M.; Howe T.; Joffe J.; Kelleher M.; Kelly S.; Kendall A.; Kristeleit H.; Lumsden G.; Macmillan C.; MacPherson I.; Malik Z.; Mithal N.; Neal A.; Panwar U.; Proctor A.; Proctor S.J.; Raj S.; Rehman S.; Sandri I.; Scatchard K.; Sherwin E.; Sims E.; Singer J.; Smith S.; Tahir S.; Taylor W.; Tsalic M.; Wardley A.; Waters S.; Wheatley D.; Wright K.; Yuille F.; Alonso I.; Artagaveytia N.; Rodriguez R.; Arbona E.; Garcia Y.; Lion L.; Marcano D.; Van Thuan T. | European Journal of Cancer | 41 | 38 | |
2007 | Should adjuvant radiotherapy to the supraclavicular fossa be routinely given in patients with breast conservative treatment? | CHUN-WEI WANG ; WEN-HUNG KUO ; KING-JEN CHANG ; CHIUN-SHENG HUANG ; CHIA-HSIEN CHENG | Journal of Surgical Oncology | 14 | 11 | |
2016 | Should pertuzumab be used as part of neoadjuvant treatment prior to the release of the APHINITY trial results? | WEI-WU CHEN ; CHING-HUNG LIN ; CHIUN-SHENG HUANG | Translational Cancer Research | 1 | 1 | |
2008 | Spatiotemporal sharpening of sub-pixel super-resolution by means of two infrared spectrum cameras for early cancer detection | Lee, C.-Y.; Hsieh, H.-Y.; Lee, S.-C.; CHIUN-SHENG HUANG ; YEUN-CHUNG CHANG ; Chen, C.-M.; CHUNG-MING CHEN ; SI-CHEN LEE | Proceedings of SPIE - The International Society for Optical Engineering | 4 | 0 | |
2014 | A spatiotemporally defined in vitro microenvironment for controllable signal delivery and drug screening | Kuo, C.-T.; Liu, H.-K.; Huang, G.-S.; Chang, C.-H.; Chen, C.-L.; Chen, K.-C.; RUBY YUN-JU HUANG ; CHING-HUNG LIN ; Lee, H.; CHIUN-SHENG HUANG ; ANDREW WO | Analyst | 16 | 14 | |
2012 | Stochastic region competition algorithm for Doppler sonography segmentation | Yeh, F.-C.; Cheng, J.-Z.; Chou, Y.-H.; Tiu, C.-M.; YEUN-CHUNG CHANG ; CHIUN-SHENG HUANG ; CHUNG-MING CHEN | Medical Physics | 1 | 1 | |
2008 | Surgical treatment for primary mammary tuberculosis - Report of three octogenarian cases and review of literature | Luh S.-P.; KING-JEN CHANG ; Cheng J.-H.; Hsu J.-D.; CHIUN-SHENG HUANG | Breast Journal | 5 | 9 | |
2017 | TGF-β1 secreted by Tregs in lymph nodes promotes breast cancer malignancy via up-regulation of IL-17RB | Huang S.-C.; Wei P.-C.; Hwang-Verslues W.W.; WEN-HUNG KUO ; YUNG-MING JENG ; Hu C.-M.; Shew J.-Y.; CHIUN-SHENG HUANG ; KING-JEN CHANG ; Lee E.Y.-H.P.; Lee W.-H. | EMBO Molecular Medicine | 40 | 40 | |
1996 | Total colonoscopy in patients with polyps in the proctosigmoid region - A Taiwanese experience | MING-JIUM SHIEH ; Wang C.-Y.; Wong J.-M.; CHIUN-SHENG HUANG ; Huang S.-H. | Digestive Endoscopy | 1 | 0 | |
2019 | Toward a fully robotic surgery: Performing robotic major liver resection with no table-side surgeon | PO-DA CHEN ; REY-HENG HU ; JIN-TUNG LIANG ; CHIUN-SHENG HUANG ; YAO-MING WU | The international journal of medical robotics + computer assisted surgery : MRCAS | 6 | 5 | |
2017 | Toxicity profile differences of adjuvant docetaxel/cyclophosphamide (TC) between Asian and Caucasian breast cancer patients | Chow L.W.C.; Biganzoli L.; Leo A.D.; Kuroi K.; Han H.S.; Patel J.; CHIUN-SHENG HUANG ; YEN-SHEN LU ; Zhu L.; Chow C.Y.C.; Loo W.T.Y.; Gl?ck S.; Toi M. | Asia-Pacific Journal of Clinical Oncology | 16 | 17 | |
2015 | TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays | CHING-HUNG LIN ; Chen I.-C.; CHIUN-SHENG HUANG ; Hu F.-C.; WEN-HUNG KUO ; KUAN-TING KUO ; Wang C.-C.; Wu P.-F.; DWANG-YING CHANG ; Wang M.-Y.; Chang C.-H.; WEI-WU CHEN ; YEN-SHEN LU ; ANN-LII CHENG | Scientific Reports | 10 | 11 | |
2023 | Transcriptomic alterations underlying metaplasia into specific metaplastic components in metaplastic breast carcinoma | HUANG-CHUN LIEN ; Hsu, Chia-Lang; YEN-SHEN LU ; WEI-WU CHEN ; I-CHUN CHEN ; Li, Yu-Chia; CHIUN-SHENG HUANG ; ANN-LII CHENG ; CHING-HUNG LIN | Breast cancer research : BCR | 0 | 0 | |
2005 | Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer | Piccart-Gebhart M.J.; Procter M.; Leyland-Jones B.; Goldhirsch A.; Untch M.; Smith I.; Gianni L.; Baselga J.; Bell R.; Jackisch C.; Cameron D.; Dowsett M.; Barrios C.H.; Steger G.; CHIUN-SHENG HUANG ; Andersson M.; Inbar M.; Lichinitser M.; L?ng I.; Nitz U.; Iwata H.; Thomssen C.; Lohrisch C.; Suter T.M.; R?schoff J.; S?to T.; Greatorex V.; Ward C.; Straehle C.; McFadden E.; Dolci M.S.; Gelber R.D. | New England Journal of Medicine | 4386 | 3899 | |
2022 | Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer | Cortés, J.; Kim, S. B.; Chung, W. P.; Im, S. A.; Park, Y. H.; Hegg, R.; Kim, M. H.; Tseng, L. M.; Petry, V.; Chung, C. F.; Iwata, H.; Hamilton, E.; Curigliano, G.; Xu, B.; CHIUN-SHENG HUANG ; et al., | New England Journal of Medicine | 329 | 328 | |
2023 | Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial | Hurvitz, Sara A; Hegg, Roberto; Chung, Wei-Pang; Im, Seock-Ah; Jacot, William; Ganju, Vinod; Chiu, Joanne Wing Yan; Xu, Binghe; Hamilton, Erika; Madhusudan, Srinivasan; Iwata, Hiroji; Altintas, Sevilay; Henning, Jan-Willem; Curigliano, Giuseppe; Perez-Garcia, José Manuel; Kim, Sung-Bae; Petry, Vanessa; CHIUN-SHENG HUANG ; et al., | Lancet (London, England) | 142 | 77 | |
2021 | Trastuzumab emtansine (T-DM1) versus trastuzumab in Chinese patients with residual invasive disease after neoadjuvant chemotherapy and HER2-targeted therapy for HER2-positive breast cancer in the phase 3 KATHERINE study | CHIUN-SHENG HUANG ; Yang, Youngsen; Kwong, Ava; Chen, Shin-Cheh; Tseng, Ling-Ming; Liu, Mei-Ching; Shen, Kunwei; Wang, Shusen; Ng, Ting-Ying; Feng, Yi; Sun, Guofang; Yan, Iris Renfei; Shao, Zhimin | Breast cancer research and treatment | 6 | 3 | |
2019 | Trastuzumab emtansine for residual invasive HER2-positive breast cancer | Von Minckwitz G.; CHIUN-SHENG HUANG ; Mano M.S.; Loibl S.; Mamounas E.P.; Untch M.; Wolmark N.; Rastogi P.; Schneeweiss A.; Redondo A.; Fischer H.H.; Jacot W.; Conlin A.K.; Arce-Salinas C.; Wapnir I.L.; Jackisch C.; DiGiovanna M.P.; Fasching P.A.; Crown J.P.; W?lfing P.; Shao Z.; Caremoli E.R.; Wu H.; Lam L.H.; Tesarowski D.; Smitt M.; Douthwaite H.; Singel S.M.; Geyer C.E.; Jr. | New England Journal of Medicine | 1510 | 1351 | |
2022 | Trastuzumab Emtansine Plus Pertuzumab Versus Taxane Plus Trastuzumab Plus Pertuzumab After Anthracycline for High-Risk Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: The Phase III KAITLIN Study | Krop, Ian E; Im, Seock-Ah; Barrios, Carlos; Bonnefoi, Hervé; Gralow, Julie; Toi, Masakazu; Ellis, Paul A; Gianni, Luca; Swain, Sandra M; Im, Young-Hyuck; De Laurentiis, Michelino; Nowecki, Zbigniew; CHIUN-SHENG HUANG ; Fehrenbacher, Louis; Ito, Yoshinori; Shah, Jigna; Boulet, Thomas; Liu, Haiying; Macharia, Harrison; Trask, Peter; Song, Chunyan; Winer, Eric P; Harbeck, Nadia | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 31 | 22 | |
2016 | TSGΔ154-1054 splice variant increases TSG101 oncogenicity by inhibiting its E3-ligase-mediated proteasomal degradation | Chua H.-H.; CHIUN-SHENG HUANG ; Weng P.-L.; TE-HUEI YEH | Oncotarget | 4 | 4 | |